American pharmaceutical company Eli Lilly said it has submitted a request to the Food and Drug Administration for emergency use of its experimental COVID-19 antibody treatment $LLY
is seeking emergency use authorization from the U.S. health regulator for its experimental COVID-19 antibody monotherapy and plans to pursue a similar approval for a combination therapy with two of its antibody drugs next month.
The data was in line with results from a September trial testing its single antibody treatment LY-CoV555. None of these drugs are yet authorized for emergency use in the United States, but an experimental two-antibody combination under development by Regeneron Pharmaceuticals IncIn a total of 268 patients with mild-to-moderate COVID-19, nearly 1% given a combination of Lilly’s two antibody treatments had to be hospitalized, compared with 5.8% on a placebo.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Lilly Asks FDA to Authorize Covid-19 Antibody DrugEli Lilly asked the FDA to authorize a Covid-19 drug that could be the first antibody treatment for patients recently diagnosed with mild to moderate cases
Read more »
Harvest Crusade pastor Greg Laurie says he has COVID-19 after White House visitAfter attending a Rose Garden ceremony at the White House, the megachurch leader has contracted the coronavirus.
Read more »
Even If Trump Beats Covid-19, Long-Term Effects May Still LingerA Centers for Disease Control and Prevention study published in July found that 35% of U.S. adults had not returned to their usual state of health two to three weeks after testing positive for Covid-19, with one in five of the respondents being 18-34 year-olds with no chronic medical conditions.
Read more »
White House Correspondents' Association Responds to Kayleigh McEnany COVID-19 DiagnosisWhite House Correspondents' Association responds to Kayleigh McEnany COVID-19 diagnosis
Read more »
President Trump is prescribed a third drug to combat his COVID-19 infectionTrump’s diagnosis highlights one of the challenges of the pandemic: There are few treatment options. He has been treated with Regeneron's antibody treatment, Gilead's remdesivir, supplemental oxygen and now dexamethasone, according to Dr. Sean Conley.
Read more »
Trump returning to White House after saying he 'learned' about COVID-19 by having itThe president's physician declined to comment on Pres. Trump telling Americans not to be afraid: 'I’m not going to get into what the president says.'
Read more »